Erratum: MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo (Cell Stem Cell (2019) 24(4) (579–591.e12), (S193459091930013X), (10.1016/j.stem.2019.01.013))

Lorna R. Fiedler, Kathryn Chapman, Min Xie, Evie Maifoshie, Micaela Jenkins, Pelin Arabacilar Golforoush, Mohamed Bellahcene, Michela Noseda, Dörte Faust, Ashley Jarvis, Gary Newton, Marta Abreu Paiva, Mutsuo Harada, Daniel J. Stuckey, Weihua Song, Josef Habib, Priyanka Narasimhan, Rehan Aqil, Devika Sanmugalingam, Robert YanLorenzo Pavanello, Motoaki Sano, Sam C. Wang, Robert D. Sampson, Sunthar Kanayaganam, George E. Taffet, Lloyd H. Michael, Mark L. Entman, Tse Hua Tan, Sian E. Harding, Caroline M.R. Low, Catherine Tralau-Stewart, Trevor Perrior, Michael D. Schneider

研究成果: Comment/debate査読

抄録

(Cell Stem Cell 24, 579–591.e1–e12; April 4, 2019) In the originally published version of our manuscript, one of the authors was incorrectly listed as “Narasimham, P.” To address this, we have now corrected the spelling of the name both here and in our original article online to “Narasimhan, P.” We apologize for the oversight and for any resulting confusion.

本文言語English
ページ(範囲)458
ページ数1
ジャーナルCell stem cell
26
3
DOI
出版ステータスPublished - 2020 3 5

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

フィンガープリント 「Erratum: MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo (Cell Stem Cell (2019) 24(4) (579–591.e12), (S193459091930013X), (10.1016/j.stem.2019.01.013))」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル